Multidisciplinary Orbital Tumor Symposium

The inaugural Wills Eye and Thomas Jefferson University Hospitals Orbital Tumor Symposium features critical deliberations regarding patient cases, clinical findings, differential diagnoses, and management plan options. Participants will examine cases from multiple perspectives and gain an in-depth understanding of how experienced health care providers approach difficult patient care decisions.

Keynote lectures from leading practitioners provide evidence for care decision discussed in panels which will increase confidence in diagnostic and treatment decision making for participants. This innovative course will be of interest to clinicians treating periorbital tumors and malignancy which includes ophthalmologists, otolaryngologists, radiation oncologists, medical oncologists, dermatologists, radiologists, and trainees.

Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Monday, June 5, 2023. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

Access to Virtual Conference

The link to access the virtual symposium will be emailed to all registrants and presenters. The link can also be found on the Course Content tab.

Agenda Updates
Updates have been made to the agenda. View current agenda.

1. Recall strategies to treat and manage orbital tumors.
2. Apply the multidisciplinary approach to managing patients with orbital tumors.
3. Explain diagnostic and therapeutic options available for the treatment and management of orbital tumors.
4. Formulate the appropriate management plans based on pathology of orbital tumors.
5. Describe the latest surgical techniques and systemic therapies for advanced orbital malignancies.

Contact [email protected] for bulk pricing.

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 4.50 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals: This educational activity is designated for 4.50 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Other Credit
 PA Patient Safety and Risk Credit: This education activity offers 1.00 PA Patient Safety and Risk credit.

Cancellation Policy
Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.* Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20).  Registrants who fail to attend the conference are responsible for the entire fee.  All refunds will be processed after the conference.  The University reserves the right to cancel or postpone this course due to unforeseen circumstances.  In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines, or travel agencies. 

*Registration fees will be refunded less a 15% administration fee to international conference registrants who are unable to secure a travel visa. Registrants must provide proof of visa denial.

Jefferson Release Policy
Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Joseph M Curry, MD
Professor
Thomas Jefferson University Hospital
Philadelphia, PA

Co-Director, Faculty

Nothing to disclose

Sara Lally, MD
Associate Professor
Shields, Shields and Lally
Philadelphia, PA

Co-Director, Faculty

Nothing to disclose

Rita S Axelrod, MD
Professor, Medical Oncology
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Voichita Bar Ad, MD
Attending Physician
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Jurij R Bilyk, MD
Professor of Ophthalmology
Wills Eye Hospital
Philadelphia, Pennsylvania

Faculty

Nothing to disclose

Hakan Demirci, MD
University of Michigan
Ann Arbor, MI

Faculty

Advisor-Aura Bioscience

James J Evans, MD
Neurosurgeon
Thomas Jefferson University
Philadelphia , PA

Faculty

Royalties or Patent Beneficiary-Mizuho

Trish Giles, BSN
Nursing
Lodi, CA

Faculty

Non-Clinical Exception

Jennifer M Johnson, MD, PhD
Assistant Professor
Thomas Jefferson University Hospital
Philadelphia, PA

Faculty

Consulting Fee-Foundation Medicine

Hatem Krema, MD
University of Toronto
Toronto, ON

Faculty

Nothing to disclose

Deepthi Kurian, MD

Faculty

Nothing to disclose

Adam J Luginbuhl, MD
Professor
Thomas Jefferson University
Conshohocken, PA

Faculty

Nothing to disclose

Tatyana Milman, MD
Staff Pathologist and Ophthalmologist
Wills Eye Hospital
Philadelphia, PA

Faculty

Nothing to disclose

Maureen Murphy, CRNP
Nurse Practitioner
Thomas Jefferson University Hospital
Philadelphia, PA

Faculty

Nothing to disclose

Neda Nikbakht, MD, PhD
Resident
Thomas Jefferson University
Philadelphia, PA

Faculty

Advisor-Helsinn Therapeutics|Advisor-Kowa Pharmaceuticals

Gurston G Nyquist, MD
Physician
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Marlana M Orloff, MD
Medical Oncologist
Thomas Jefferson University
Philadelphia, PA

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Ideaya|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Replimune|Paid consultant-Immunocore

Rino S Seedor, MD
Attending Physician
Jefferson Hospital
Philadelphia, PA

Faculty

Nothing to disclose

Karine Shebaclo, MD

Faculty

Nothing to disclose

Iyar Sheps, MD
University of Calgary
Calgary, Canada

Faculty

Nothing to disclose

Carol Shields, MD
Director, Oncology Service
Wills Eye Hospital
Philadelphia, PA

Faculty

Advisor-Immunocore

Konica Singla, MD
Wills Eye Hospital
Philadelphia, PA

Faculty

Nothing to disclose

George Thomas, MD, FAMS, FRCOphth
Dr
Will's Eye Hospital
Philadelphia, PA

Faculty

Nothing to disclose

Vijitha S Vempuluru, MD
Wills Eye Hospital
Philadelphia, PA

Faculty

Grant or research support-Victoria Cohen Eye Cancer Charitable Trust

Alison Watson, MD
Associate Professor of Ophthalmology
Sidney Kimmel Medical College
Philadelphia, PA

Faculty

Nothing to disclose

Ezekiel Weis, MD
Professor
University of Alberta
calgary, Canada

Faculty

Nothing to disclose

Joanne Gauthier, BS
Business Manager
Thomas Jefferson University
Philadelphia, PA

Other Planning Committee Member

Nothing to disclose

Emilia Minhondo, BS
Clinical Executive Assistant
Thomas Jefferson University
Philadelphia, PA

Other Planning Committee Member

Nothing to disclose

Friday, April 21, 2023

Any commercial or in-kind support received will be announced prior to the start of the activity.

Virtual exhibiting opportunities are available for this activity. If interested, please email [email protected]

 To view a PDF of the exhibitor prospectus, click here.

 Additional Benefits for Exhibitors

• List of conference attendees
• Company listing in digital Exhibitor Directory
• Company acknowledgement verbally and on PowerPoint slideshow during opening remarks or during conference breaks.
• Company acknowledgement in reminder and follow-up emails to attendees

Exhibitor Rules

• Exhibitor is not providing commercial support for this educational activity. Exhibitor is purchasing virtual exhibit space.
• Exhibits are intended for informational purposes, products should not be sold through the virtual exhibit hall.
• TJU and the exhibitor acknowledge and agree that the exhibitor may be subject to Section 6002 of the Affordable Care Act, which added Section 1128G to the Social Security Act, and its implementing regulations codified in 42 CFR 402 &403 (Collectively the Sunshine Act). Exhibiting companies are solely responsible for collecting any information about actions within their virtual exhibit space that constitutes a payment or transfer of value to a covered participant, which is required to reported under the Sunshine Act.
• Exhibitors may observe educational sessions but must refrain from participating in the activity.
• No recordings of the scientific sessions on behalf of the exhibitor's company is permitted.

Application Deadline
Applications for virtual exhibits will be accepted through Friday, April 7, 2023. After Friday, April 7, 2023, applications may be accepted on a case by case basis. No application will be accepted after Friday, April 14, 2023.

Cancellation and Refunds
In the event that the symposium is canceled by the organizers, exhibit fees will be refunded in full, however Thomas Jefferson University is not responsible for other expenses incurred by the exhibitor.

In the event an exhibitor cancels participation, refunds will be made as follows:

• Prior to the deadline of Friday, April 14, 2023, a refund will be given minus a $200 administration fee.
• After  Friday, April 14, 2023, no refund will be given.
• Exhibitors who are absent from the conference will not receive a refund.
• Exhibit cancellations must be made in writing. Send cancellation notice to [email protected] and include name of activity in subject line.